US6352856B1ExpiredUtility
Chimeric poxvirus comprising sequences of a retroviral vector component
Est. expiryJan 16, 2018(expired)· nominal 20-yr term from priority
C12N 2740/13044C12N 15/86C12N 2710/24143
60
PatentIndex Score
15
Cited by
37
References
15
Claims
Abstract
A chimeric poxvirus is disclosed, which comprises the sequences of the vector component of a retroviral vector particle and optionally the packaging component of a defective retroviral particle. The chimeric poxvirus according to the invention particularly can be used for applications in gene therapy or tumor therapy.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1. A chimeric poxvirus comprising a poxvirus genome comprising stably inserted therein a replication defective retroviral proviral genome under transcriptional control of a promoter, wherein a foreign gene sequence under transcriptional control of a promoter is inserted into said retroviral genome.
2. The chimeric poxvirus as set forth in claim 1 , further comprising a packaging component sequence.
3. A chimeric poxvirus as set forth in claim 1 , wherein said poxvirus is a chordopox virus.
4. A chimeric poxvirus as set forth in claim 1 , wherein said poxvirus is an orthopox virus.
5. A chimeric poxvirus as set forth in claim 4 , wherein said orthopox virus is a vaccinia virus.
6. A chimeric poxvirus as set forth in claim 6 , wherein said vaccinia virus is a defective vaccinia virus.
7. The chimeric poxvirus as set forth in claim 1 , wherein said retroviral genome is under transcriptional control of a poxvirus promoter.
8. The chimeric poxvirus as set forth in claim 2 , wherein said packaging component sequence is under transcriptional control of a poxvirus promoter.
9. The chimeric poxvirus as set forth in claim 7 , wherein said poxvirus promoter is an early poxvirus promoter.
10. A chimeric poxvirus as set forth in claim 8 , wherein said poxvirus promoter is an early poxvirus promoter.
11. The chimeric poxvirus as set forth in claim 1 , wherein said retroviral genome sequence comprises introns.
12. The chimeric poxvirus as set forth in claim 1 , wherein said retroviral genome sequence comprises an internal polyadenylation sequence.
13. A defective retroviral particle comprising an intron-containing genome.
14. A method for producing a defective retroviral particle comprising a foreign gene sequence, wherein the method comprises
infecting a cell of a packaging cell line with a chimeric poxvirus comprising a poxvirus genome having stably inserted therein a replication defective retroviral genome under transcriptional control of a promoter, wherein a foreign gene sequence under transcriptional control of a promoter is inserted into said retroviral genome, and wherein the infected cell produces a defective retroviral particle.
15. A method for producing a defective retroviral particle comprising a foreign gene sequence, wherein the method comprises
infecting a cell of a cell line with a chimeric poxvirus comprising a poxvirus genome having stably inserted therein a replication defective retroviral genome under transcriptional control of a promoter, wherein a foreign gene sequence under transcriptional control of a promoter is inserted into said retroviral genome and retroviral packaging components under transcriptional control of a promoter, and wherein the infected cell produces a defective retroviral particle.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.